You are here: Home > Institute of Excellence (CPD) > CPD Events > Glaucoma 1: Pharmacology

Glaucoma 1: Pharmacology

Available from: 13/12/2018

Where to publish: www.lucotticalearning.com.au

Provider: Luxottica Institute of Learning

Contact: Nikki Byrne, [E] iol@luxottica.com.au, [P] 02 8336 8616

Learning Objectives

  • understand the indications, contraindications, dosing, and adverse effects associated with prostaglandin analogues
  • . understand how the sympathetic and parasympathetic nervous system is used to develop medications to treat glaucoma
  • . understand the indications, contraindications, dosing, and adverse effects associated with cholinergic agonists.
  • understand the indications, contraindications, dosing, and adverse effects associated with alpha adrenergic agonists
  • . understand the indications, contraindications, dosing, and adverse effects associated with beta blockers.
  • understand the indications, contraindications, dosing, and adverse effects associated with carbonic anhydrase inhibitors
  • understand the indications, contraindications, dosing, and adverse effects associated with RhoKinase inhibitors.
  • understand the role of nitric oxide and nitric oxide-donating prostaglandin analogues in reducing intraocular pressure
  • understand the novel actions of RhoKinase inhibitors in reducing intraocular pressure.
  • understand the true contraindications for beta blockers and discern which adverse effects are not due to beta blockade

Max points awarded: 2.00

Session Information

Name
Glaucoma 1: Pharmacology
Activity Type
Independent Learning with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.00

NameActivity TypeTherapeutic?Manufacturer/
Supplier?
Points for attending &
Passing Assessment
Glaucoma 1: PharmacologyIndependent Learning with AssessmentYesNo2.00

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.